Lichen China (NASDAQ:LICN – Get Rating) and CGI (NYSE:GIB – Get Rating) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, valuation and risk.
This is a summary of recent ratings and price targets for Lichen China and CGI, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
CGI has a consensus target price of $139.11, suggesting a potential upside of 35.51%. Given CGI’s higher possible upside, analysts plainly believe CGI is more favorable than Lichen China.
Insider & Institutional Ownership
This table compares Lichen China and CGI’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Earnings and Valuation
This table compares Lichen China and CGI’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Lichen China||$33.81 million||1.87||N/A||N/A||N/A|
|CGI||$13.67 billion||1.77||$1.15 billion||$4.82||21.30|
CGI has higher revenue and earnings than Lichen China.
CGI beats Lichen China on 8 of the 9 factors compared between the two stocks.
About Lichen China
Lichen China Limited focuses on providing financial and taxation solution services, education support services, and software and maintenance services under its Lichen brand. Lichen China Limited is based in JINJIANG, China.
CGI, Inc. engages in the provision of information technology and consulting services. It operates through the following segments: Western and Southern Europe, U.S. Commercial and State Government, Canada, U.S. Federal, Scandinavia and Central Europe, UK and Australia; Finland, Poland, and Baltics, Northwest and Central-East Europe, and Asia Pacific. The company was founded by Serge Godin and Andre Imbeau in June 1976 and is headquartered in Montreal, Canada.
Receive News & Ratings for Lichen China Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lichen China and related companies with MarketBeat.com's FREE daily email newsletter.